Search

everythinglearnresearchcommunity

for

Search:↓

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Two new compounds were found to effectively reduce hair growth in mice.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Protocatechuic acid can reduce melanin production and boost antioxidant activity in hair follicles.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Gene variation affects prostate issues and hair loss.

Letrozole may help prevent seizures by reducing certain hormone levels.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

The treatment was effective for advanced non-Hodgkin's lymphomas.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Agmatine may help reduce seizures linked to hormone changes in female rats.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.